530317 logo

Godavari Drugs Limited Stock Price

BSE:530317 Community·₹550.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

530317 Share Price Performance

₹73.07
-53.73 (-42.37%)
₹73.07
-53.73 (-42.37%)
Price ₹73.07

530317 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with mediocre balance sheet.

2 Risks
1 Reward

Godavari Drugs Limited Key Details

₹1.1b

Revenue

₹791.4m

Cost of Revenue

₹270.1m

Gross Profit

₹233.1m

Other Expenses

₹37.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 14, 2026
4.92
25.44%
3.49%
162.9%
View Full Analysis

About 530317

Founded
1987
Employees
106
CEO
Mukund Kakani
WebsiteView website
godavaridrugs.com

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.

Recent 530317 News & Updates

Recent updates

No updates